Capstone Investment Advisors’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
VPM
VCM
Capstone Investment Advisors's EXEL Position: Q1 2026 in Review
Capstone Investment Advisors increased its Exelixis (EXEL) stake by 19% in Q1 2026, buying an estimated $61K and bringing the position to 8,950 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1267.
Capstone Investment Advisors first reported a position in EXEL in Q1 2014 and has held it in 8 quarters since. The position peaked at $802K in Q2 2025. 697 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Capstone Investment Advisors held 8,950 shares of Exelixis worth $384K as of Q1 2026.
- Capstone Investment Advisors bought 1,419 Exelixis shares in Q1 2026, an estimated $61K.
- Exelixis made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1267 holding.
- Capstone Investment Advisors first reported a position in Exelixis in Q1 2014 and has held it in 8 quarters since.
- Capstone Investment Advisors's Exelixis position peaked at $802K in Q2 2025.
- 697 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.